Literature DB >> 9192747

Use of recombinant human erythropoietin outside the setting of uremia.

M Cazzola1, F Mercuriali, C Brugnara.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9192747

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  25 in total

1.  Erythropoietin in liver cirrhosis: two questions without answers.

Authors:  Cosimo-Marcello Bruno; Claudio Sciacca; Danila Cilio; Gaetano Bertino; Rinaldo Pellicano
Journal:  World J Gastroenterol       Date:  2005-06-21       Impact factor: 5.742

2.  Successful treatment of a hemodialyzed patient with pure red cell aplasia associated with epoetin beta pegol therapy with cyclosporine.

Authors:  Keiji Hirai; Susumu Ookawara; Haruhisa Miyazawa; Kiyonori Ito; Yuichiro Ueda; Yoshio Kaku; Taro Hoshino; Shun-Ichi Kimura; Izumi Yoshida; Sachiko Kakuta; Yoshiyuki Morishita; Kaoru Tabei
Journal:  CEN Case Rep       Date:  2015-09-15

3.  Erythropoietin induces tumor regression and antitumor immune responses in murine myeloma models.

Authors:  M Mittelman; D Neumann; A Peled; P Kanter; N Haran-Ghera
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-17       Impact factor: 11.205

Review 4.  The diagnostic plot: a concept for identifying different states of iron deficiency and monitoring the response to epoetin therapy.

Authors:  Christian Thomas; Andreas Kirschbaum; Dieter Boehm; Lothar Thomas
Journal:  Med Oncol       Date:  2006       Impact factor: 3.064

Review 5.  Detection of DNA-recombinant human epoetin-alfa as a pharmacological ergogenic aid.

Authors:  Randall L Wilber
Journal:  Sports Med       Date:  2002       Impact factor: 11.136

Review 6.  Supportive care for patients with early breast cancer.

Authors:  Laura García-Estévez; Ignasi Tusquets; Isabel Alvarez; César Rodríguez; Yolanda Fernández; Miguel Angel Seguí; Jesús García-Mata; Ana Lluch
Journal:  Clin Transl Oncol       Date:  2010-01       Impact factor: 3.405

7.  Plasma erythropoietin levels in anaemic and non-anaemic patients with chronic liver diseases.

Authors:  Cosimo Marcello Bruno; Sergio Neri; Claudio Sciacca; Gaetano Bertino; Pietro Di Prima; Danila Cilio; Rinaldo Pellicano; Luciano Caruso; Raffaello Cristaldi
Journal:  World J Gastroenterol       Date:  2004-05-01       Impact factor: 5.742

8.  Traumatic Optic Neuropathy - A Conundrum.

Authors:  Vinoth Kanna Selvaraj; Ramachandran Viswanathan; Vasudevan Devanathan
Journal:  J Clin Diagn Res       Date:  2016-03-01

Review 9.  A risk-benefit assessment of epoetin in the management of anaemia associated with cancer.

Authors:  Y Beguin
Journal:  Drug Saf       Date:  1998-10       Impact factor: 5.606

Review 10.  Management options for cancer therapy-related anaemia.

Authors:  Tim J Littlewood
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.